Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04637 (
p53
)
77,613
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Transcription factor II H
(
TFIIH
) is comprised of core
TFIIH
and Cdk-activating kinase (CAK) complexes. Here, we investigated the molecular and cellular manifestation of the
TFIIH
compositional changes by XPG truncation mutations. We showed that both core
TFIIH
and CAK are rapidly recruited to damage sites in repair-proficient cells. Chromatin immunoprecipitation against
TFIIH
and CAK components revealed a physical engagement of CAK in nucleotide excision repair (NER). While XPD recruitment to DNA damage was normal, CAK was not recruited in severe XP-G and XP-G/CS cells, indicating that the associations of CAK and XPD to core
TFIIH
are differentially affected. A CAK inhibition approach showed that CAK activity is not required for assembling pre-incision machinery in vivo or for removing genomic photolesions. Instead, CAK is involved in Ser5-phosphorylation and UV-induced degradation of RNA polymerase II. The CAK inhibition impaired transcription from undamaged and UV-damaged reporter, and partially decreased transcription of
p53
-dependent genes. The overall results demonstrated that a) XP-G/CS mutations affect the disassembly state of
TFIIH
resulting in the dissociation of CAK, but not XPD from core
TFIIH
, and b) CAK activity is not essential for global genomic repair but involved in general transcription and damage-induced RNA polymerase II degradation.
...
PMID:Dissociation of CAK from core TFIIH reveals a functional link between XP-G/CS and the TFIIH disassembly state. 2054 86